Subjects with ages between 18 and 65 years, who are scheduled for a dermatologic surgical excision
Subjects requiring surgical excisions for any condition
Subjects with any Fitzpatrick skin type
Willingness to participate in the study
Willingness to receive experimental treatment
Informed consent agreement signed by the subject
Willingness to follow the follow-up schedule
Willingness to not use any other scar treatments during the study period (i.e scar massage, over-the-counter silicone pads, intralesional steroid of 5-fluorouracil injections, laser treatments)
You may not be if
Pregnancy
Prior scar in area to be treated
Known photoallergy to visible light (i.e polymorphous light eruption)
Subject is unable to comply with treatment or follow-up visits
Subject with a history of being on photosensitive medications for the past 3 months (thiazides \[used to treat high blood pressure\], tetracyclines, fluoroquinolones griseofulvin or sulfonamides \[used to treat infections\], sulfonylureas \[used to treat diabetes\], calcium channel blockers \[used to treat hypertension\], phenothiazines \[used to treat serious emotional problems\]).
Known autoimmune disease (some autoimmune diseases can lead to sensitivity to light, such as lupus erythematosus)
Subject is currently enrolled in a clinical study of any other unapproved investigational drug or device
Clareo Health | Pulsed-dye Laser Treatment Prior to Surgical Excision
